Shuttle Pharmaceuticals Holdings (SHPH) Change in Account Payables (2021 - 2024)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Change in Account Payables came in at -$446.0 in Q1 2024, up 96.43% year-on-year from -$227.05 in Q2 2023, and down 200.0% quarter-over-quarter from $446.0 in Q4 2023.
Shuttle Pharmaceuticals Holdings (SHPH) Change in Account Payables (2021 - 2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Change in Account Payables history runs 4 years deep, the most recent figure standing at -$446.0 for Q1 2024.
- On a quarterly basis, Change in Account Payables rose 96.43% year-over-year to -$446.0 in Q1 2024; TTM through Dec 2024 was -$446.0, a 96.3% increase from a year earlier, with the FY2024 full-year figure at -$446.0, up 96.3% from the prior year.
- Change in Account Payables eased to -$446.0 in Q1 2024 per SHPH's latest filing, from $446.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $404973.0 in Q4 2022 and bottomed at -$12500.0 in Q1 2023.
- The 4-year median for Change in Account Payables is $446.0 (2023), against an average of $140034.8.
- Across the five-year window, Change in Account Payables plunged 99.89% in 2023 and jumped 96.43% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $307701.0 in 2021, then surged by 31.61% to $404973.0 in 2022, then plunged by 99.89% to $446.0 in 2023, then sank by 200.0% to -$446.0 in 2024.
- Per Business Quant, the three latest SHPH Change in Account Payables figures stand at -$446.0 (Q1 2024), $446.0 (Q4 2023), and -$12500.0 (Q1 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -446.00 |
| Mar 31, 2024 | -446.00 |
| Dec 31, 2023 | 446.00 |
| Dec 31, 2023 | 446.00 |
| Mar 31, 2023 | -12,500.00 |
| Mar 31, 2023 | -12,500.00 |
| Dec 31, 2022 | 404,973.00 |
| Dec 31, 2022 | 404,973.00 |
| Dec 31, 2021 | 307,701.00 |
| Dec 31, 2021 | 307,701.00 |